CLONING AND STRUCTURAL CHARACTERIZATION OF ECTACC, A NEW MEMBER OF THE TRANSFORMING ACIDIC COILED COIL (TACC) GENE FAMILY: cDNA SEQUENCE AND EXPRESSION ANALYSIS IN HUMAN MICROVASCULAR ENDOTHELIAL CELLS

Cytokine ◽  
2001 ◽  
Vol 13 (3) ◽  
pp. 129-137 ◽  
Author(s):  
Jeffrey J. Pu ◽  
Chaoyang Li ◽  
Marilis Rodriguez ◽  
Debendranath Banerjee
2007 ◽  
Vol 293 (6) ◽  
pp. H3325-H3332 ◽  
Author(s):  
Derek B. J. Bone ◽  
James R. Hammond

Levels of cardiovascular active metabolites, like adenosine, are regulated by nucleoside transporters of endothelial cells. We characterized the nucleoside and nucleobase transport capabilities of primary human cardiac microvascular endothelial cells (hMVECs). hMVECs accumulated 2-[3H]chloroadenosine via the nitrobenzylmercaptopurine riboside-sensitive equilibrative nucleoside transporter 1 (ENT1) at a Vmaxof 3.4 ± 1 pmol·μl−1·s−1, with no contribution from the nitrobenzylmercaptopurine riboside-insensitive ENT2. Inhibition of 2-chloroadenosine uptake by ENT1 blockers produced monophasic inhibition curves, which are also compatible with minimal ENT2 expression. The nucleobase [3H]hypoxanthine was accumulated within hMVECs ( Km= 96 ± 37 μM; Vmax= 1.6 ± 0.3 pmol·μl−1·s−1) despite the lack of a known nucleobase transport system. This novel transporter was dipyridamole-insensitive but could be inhibited by adenine ( Ki= 19 ± 7 μM) and other purine nucleobases, including chemotherapeutic analogs. A variety of other cell types also expressed the nucleobase transporter, including the nucleoside transporter-deficient PK( 15 ) cell line (PK15NTD). Further characterization of [3H]hypoxanthine uptake in the PK15NTD cells showed no dependence on Na+or H+. PK15NTD cells expressing human ENT2 accumulated 4.5-fold more [3H]hypoxanthine in the presence of the ENT2 inhibitor dipyridamole than did PK15NTD cells or hMVECs, suggesting trapping of ENT2-permeable metabolites. Understanding the nucleoside and nucleobase transporter profiles in the vasculature will allow for further study into their roles in pathophysiological conditions such as hypoxia or ischemia.


2011 ◽  
Vol 82 (2) ◽  
pp. 97-104 ◽  
Author(s):  
Dodanim Talavera-Adame ◽  
Tina T. Ng ◽  
Ankur Gupta ◽  
Silvia Kurtovic ◽  
Gordon D. Wu ◽  
...  

1996 ◽  
Vol 134 (1) ◽  
pp. 51-60 ◽  
Author(s):  
Armin E Heufelder ◽  
Peter C Scriba

Heufelder AE, Scriba PC. Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Graves' ophthalmopathy. Eur J Endocrinol 1996:134:51–60 T lymphocytes have been demonstrated recently to play an important role in the pathogenesis and propagation of Graves' ophthalmopathy (GO). Recruitment of T cells to the retroorbital tissue in GO involves the activation of certain adhesion molecules both in the vascular endothelium and in the extravascular connective tissue within the retroorbital space. To characterize the interactions between orbital endothelial cells (OECs) and circulating T cells in vitro, we designed a two-step immunopurification procedure with bead-immobilized Ulex europaeus I lectin and anti-human endothelial cell antigen (CD3I) monoclonal antibody for rapid and reproducible isolation of highly pure microvascular endothelial cell populations from small quantities of retroorbital connective tissue. Endothelial origin of the resulting cell populations was confirmed by positive immunoreactivity for von Willebrand factor. CD 3 I and thrombomodulin. Under baseline conditions, GO-OECs, but not normal OECs, expressed intercellular adhesion molecule 1 (ICAM-1) and CD44 immunoreactivity but no immunoreactivity for endothelial leukocyte adhesion molecule I (ELAM-1) and vascular cell adhesion molecule I (VCAM-1) was detected. Exposure of GO-OEC and normal OEC monolayers to interferon γ, interleukin 1 α and tumor necrosis factor α resulted in marked up-regulation of immunoreactivity for ICAM-1 and in induction of ELAM-1 and VCAM-1. Blocking experiments using monoclonal antibodies directed against various adhesion molecules demonstrated that interactions between matched activated T lymphocytes and OECs were mediated by integrin-dependent ICAM-1/leukocyte function-associated antigen 1 (LFA-1): VCAM-1/very late antigen 4 (VLA-4)) and integrin-independent (CD44) pathways, and revealed marked differences when comparing GO-OECs and normal OECs. In conclusion, the availability of OECs from affected retroorbital tissue of patients with GO provides a valuable tool for studying further the mechanisms responsible for orbit-specific lymphocyte recruitment in GO. Armin E Heufelder, Molecular Thyroid Research Unit, Medizinische Klinik, Klinikum Innenstadt, Ziemssenstrasse 1, 80336 München, Germany


2010 ◽  
Vol 44 (2) ◽  
pp. 125-130 ◽  
Author(s):  
Zhang Xiaozhuang ◽  
Luo Xianqiong ◽  
Jiang Jingbo ◽  
Huang Shuiqing ◽  
Yan Jie ◽  
...  

1990 ◽  
Vol 51 (6) ◽  
pp. 645-650 ◽  
Author(s):  
François Marceau ◽  
Hélène M. Boisjoly ◽  
Eric Wagner ◽  
Simone Lille ◽  
Raynald Roy

2018 ◽  
Vol 17 (1) ◽  
Author(s):  
Mónica Muñoz-Vega ◽  
Felipe Massó ◽  
Araceli Páez ◽  
Elizabeth Carreón-Torres ◽  
Hector A. Cabrera-Fuentes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document